Institutional Ownership
Prelude Therapeutics Inc
CUSIP 74065P101COMPRLDQ1 2026
Institutional Holders
52
13F filers
Shares Held
29.38M
Aggregate institutional
Institutional Value
$98.53M
Q1 2026
Net New Holders
+6
10 new · 4 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions10
Increased20
Decreased11
Sold out4
Institutional Holders
52 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 10.91M | $37.31M | 0 | Held |
| 2 | Baker Bros. Advisors LP | 10.12M | $34.62M | 0 | Held |
| 3 | Kynam Capital Management, LP | 1.59M | $5.45M | +803.7K | Added |
| 4 | Ecor1 Capital, LLC | 947.0K | $3.24M | +947.0K | New |
| 5 | Two Sigma Investments, LP | 923.6K | $3.16M | +134.9K | Added |
| 6 | Sphera Funds Management Ltd. | 558.3K | $1.91M | +435.6K | Added |
| 7 | Millennium Management LLC | 382.7K | $1.31M | +231.7K | Added |
| 8 | Marshall Wace, LLP | 358.9K | $1.23M | +85.0K | Added |
| 9 | Morgan Stanley | 322.2K | $1.10M | −12.8K | Reduced |
| 10 | Blackrock, Inc. | 321.9K | $1.10M | +55.6K | Added |
42 more institutional holders on Premium
See every fund holding Prelude Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders